The elevation in hepatic glycogen content in the rats with T2D may be the result of high circulating blood glucose levels combined with hyperinsulinemia with insulin therapy (Chatila and West, 1996; Julián et al., 2015). This evidence concerns the gene INS and hyperinsulinism.